Ticker: The Quest to Create an Artificial Heart

Ticker: The Quest to Create an Artificial Heart

By Mimi Swartz

"Swartz takes readers on [a]. . . behind-the-scenes journey into a heart surgeon's. . . quest to develop an artificial heart--a reliable, implantable device that would extend the lives of patients who have no other recourse. . . Chronicling the evolution of cardiac medicine, from pioneering efforts in open heart surgery and bypass operations under Michael DeBakey and Denton Cooley, to the advent of valve replacement and heart transplants, and protege Bud Frazier's introduction of the Left Ventricle Assist Device (or LVAD).

READ FULL DESCRIPTION

Quantity Price Discount
List Price $27.00  
1 - 24 $22.95 15%
25 - 99 $16.74 38%
100 - 249 $16.20 40%
250 - 499 $15.66 42%
500 + $15.39 43%

Quick Quote

Lorem ipsum dolor sit amet, consectetur adipisicing elit

Non-returnable discount pricing

$27.00


Book Information

Publisher: Crown Publishing Group (NY)
Publish Date: 08/07/2018
Pages: 336
ISBN-13: 9780804138000
ISBN-10: 0804138001
Language: English

Full Description

It wasn't supposed to be this hard. If America could send a man to the moon, shouldn't the best surgeons in the world be able to build an artificial heart? In Ticker, Texas Monthly executive editor and two time National Magazine Award winner Mimi Swartz shows just how complex and difficult it can be to replicate one of nature's greatest creations. Part investigative journalism, part medical mystery, Ticker is a dazzling story of modern innovation, recounting fifty years of false starts, abysmal failures and miraculous triumphs, as experienced by one the world's foremost heart surgeons, O.H. "Bud" Frazier, who has given his life to saving the un-savable. His journey takes him from a small town in west Texas to one of the country's most prestigious medical institutions, The Texas Heart Institute, from the halls of Congress to the animal laboratories where calves are fitted with new heart designs. The roadblocks to success --medical setbacks, technological shortcomings, government regulations - are immense. Still, Bud and his associates persist, finding inspiration in the unlikeliest of places. A field beside the Nile irrigated by an Archimedes screw. A hardware store in Brisbane, Australia. A seedy bar on the wrong side of Houston. Until post WWII, heart surgery did not exist. Ticker provides a riveting history of the pioneers who gave their all to the courageous process of cutting into the only organ humans cannot live without. Heart surgeons Michael DeBakey and Denton Cooley, whose feud dominated the dramatic beginnings of heart surgery. Christian Barnaard, who changed the world overnight by performing the first heart transplant. Inventor Robert Jarvik, whose artificial heart made patient Barney Clark a worldwide symbol of both the brilliant promise of technology and the devastating evils of experimentation run amuck. Rich in supporting players, Ticker introduces us to Bud's brilliant colleagues in his quixotic quest to develop an artificial heart: Billy Cohn, the heart surgeon and inventor who devotes his spare time to the pursuit of magic and music; Daniel Timms, the Brisbane biomedical engineer whose design of a lightweight, pulseless heart with but a single moving part offers a new way forward. And, as government money dries up, the unlikeliest of backers, Houston's furniture king, Mattress Mack. In a sweeping narrative of one man's obsession, Swartz raises some of the hardest questions of the human condition. What are the tradeoffs of medical progress? What is the cost, in suffering and resources, of offering patients a few more months, or years of life? Must science do harm to do good? Ticker takes us on an unforgettable journey into the power and mystery of the human heart.

About the Author

Mimi Swartz is a long-time executive editor at Texas Monthly, and a two-time National Magazine Award winner and a four time finalist. The coauthor of the national bestseller Power Failure , with Sherron Watkins, about the failures at Enron, her work has appeared in Vanity Fair , The New Yorker , Esquire , Slate , and her op-ed pieces appear regularly in the New York Times.

Learn More

We have updated our privacy policy. Click here to read our full policy.